Tolterodine SR Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Tolterodine SR Pellets

Tolterodine SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Tolterodine Tartrate as the active ingredient. These pellets are designed for incorporation into oral dosage formulations where a sustained-release profile and multiparticulate delivery system are required.

Tolterodine Tartrate has the molecular formula C₂₆H₃₇NO₇, molecular weight 475.6 g/mol, and CAS Number 124937-52-6. PubChem also lists 209747-05-7 as another CAS identifier for Tolterodine Tartrate.

Published Indian pharmaceutical pellet portfolios list Tolterodine SR Pellets at 2% strength, making 2% a commonly documented pellet loading for this product.

Key Features

  • Pharmaceutical-grade Tolterodine SR Pellets
  • Tolterodine Tartrate-based formulation
  • 2% strength commonly available in commercial pellet portfolios
  • Sustained-release multiparticulate format
  • Suitable for oral dosage-form development
  • Suitable for capsule-filling applications
  • Product-specific active ingredient loading
  • Formulation flexibility
  • Controlled quality parameters
  • Suitable for bulk pharmaceutical formulation requirements

Available Strength

Tolterodine SR Pellets – 2%

The 2% strength is documented in Indian commercial pellet product portfolios. The final SDP strength should be aligned with the approved SDP product specification.

Applications

Tolterodine SR Pellets can be considered for:

  • Sustained-release capsule formulations
  • Multiparticulate oral dosage forms
  • Capsule-filling applications
  • Modified-release formulation development
  • Pharmaceutical formulation development
  • Bulk pellet requirements
  • Oral solid dosage-form manufacturing

Product Characteristics

Tolterodine Tartrate is the tartrate salt form of Tolterodine. The finished Tolterodine SR pellet system contains the active ingredient together with formulation components used to achieve the intended pellet characteristics and release profile.

The finished pellet's assay, moisture, impurities, particle-size distribution and release characteristics should be evaluated against the applicable finished-product specification. API specifications should not automatically be transferred to the finished pellet.

Why Tolterodine SR Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellets
  • 2% Pellet Strength
  • Sustained-Release Format
  • Multiparticulate Formulation
  • Product-Specific Active Loading
  • Capsule-Filling Compatibility
  • Formulation Flexibility
  • Controlled Quality Parameters
  • Bulk Pharmaceutical Supply

Packaging & Supply

Tolterodine SR Pellets can be supplied according to the required strength, quantity, packaging configuration and applicable product specifications. Packaging should provide appropriate protection from moisture and environmental exposure during storage and transportation.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 90.0% – 110.0%
Loss on Drying NMT 5.0%
Residue on Ignition NMT 0.2%
Heavy Metals NMT 20 ppm
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 5.0%
Get Bulk Quote via WhatsApp